Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Good

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|July 18, 2002
Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replicationGeorge W Koszalka, Nelson W Johnson, Steven S Good, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2021
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 <i>In Vitro</i> and a Promising Oral Antiviral for Treatment of COVID-19Steven S Good, Jonna Westover, Kie Hoon Jung, et al.
The British Journal of Oral & Maxillofacial Surgery|September 13, 2008
Psychological characteristics of women who require orthognathic surgery: comparison with untreated controlsD M Williams, R Bentley, M T Cobourne, et al.
Patient Education and Counseling|March 8, 2013
Physician-patient communication about dietary supplementsDerjung M Tarn, Debora A Paterniti, Jeffrey S Good, et al.
Advances in Experimental Medicine and Biology|November 5, 1999
Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus diseaseJ Chulay, K Biron, L Wang, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2019
Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosisElina Berliba, Maxim Bogus, Frédéric Vanhoutte, et al.
Platelets|January 18, 2014
Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapyRichard I S Good, Anne McGarrity, Rory Sheehan, et al.
Frontiers in Oncology|May 16, 2018
The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic ReviewJonathan M Fussey, Jennifer L Bryant, Nikolaos Batis, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 23, 2015
Pharmacokinetics of IDX184, a liver-targeted oral prodrug of 2'-methylguanosine-5'-monophosphate, in the monkey and formulation optimization for human exposureXin-Ru Pan-Zhou, Benjamin A Mayes, Hassan Rashidzadeh, et al.
Contemporary Clinical Trials|December 8, 2016
Protocol of the KTFT-TALK study to reduce racial disparities in kidney transplant evaluation and living donor kidney transplantationKellee Bornemann, Emilee Croswell, Menna Abaye, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|July 18, 2002
Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replicationGeorge W Koszalka, Nelson W Johnson, Steven S Good, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2021
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 <i>In Vitro</i> and a Promising Oral Antiviral for Treatment of COVID-19Steven S Good, Jonna Westover, Kie Hoon Jung, et al.
The British Journal of Oral & Maxillofacial Surgery|September 13, 2008
Psychological characteristics of women who require orthognathic surgery: comparison with untreated controlsD M Williams, R Bentley, M T Cobourne, et al.
Patient Education and Counseling|March 8, 2013
Physician-patient communication about dietary supplementsDerjung M Tarn, Debora A Paterniti, Jeffrey S Good, et al.
Advances in Experimental Medicine and Biology|November 5, 1999
Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus diseaseJ Chulay, K Biron, L Wang, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2019
Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosisElina Berliba, Maxim Bogus, Frédéric Vanhoutte, et al.
Platelets|January 18, 2014
Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapyRichard I S Good, Anne McGarrity, Rory Sheehan, et al.
Frontiers in Oncology|May 16, 2018
The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic ReviewJonathan M Fussey, Jennifer L Bryant, Nikolaos Batis, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 23, 2015
Pharmacokinetics of IDX184, a liver-targeted oral prodrug of 2'-methylguanosine-5'-monophosphate, in the monkey and formulation optimization for human exposureXin-Ru Pan-Zhou, Benjamin A Mayes, Hassan Rashidzadeh, et al.
Contemporary Clinical Trials|December 8, 2016
Protocol of the KTFT-TALK study to reduce racial disparities in kidney transplant evaluation and living donor kidney transplantationKellee Bornemann, Emilee Croswell, Menna Abaye, et al.
Pageof 11